JP2009534458A5 - - Google Patents

Download PDF

Info

Publication number
JP2009534458A5
JP2009534458A5 JP2009507166A JP2009507166A JP2009534458A5 JP 2009534458 A5 JP2009534458 A5 JP 2009534458A5 JP 2009507166 A JP2009507166 A JP 2009507166A JP 2009507166 A JP2009507166 A JP 2009507166A JP 2009534458 A5 JP2009534458 A5 JP 2009534458A5
Authority
JP
Japan
Prior art keywords
independently
ring
alkyl
substituent
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009507166A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009534458A (ja
Filing date
Publication date
Priority claimed from GB0608269A external-priority patent/GB0608269D0/en
Application filed filed Critical
Priority claimed from PCT/GB2007/001537 external-priority patent/WO2007125331A2/en
Publication of JP2009534458A publication Critical patent/JP2009534458A/ja
Publication of JP2009534458A5 publication Critical patent/JP2009534458A5/ja
Withdrawn legal-status Critical Current

Links

JP2009507166A 2006-04-26 2007-04-26 アミノ−エチル−アミノ−アリール(aeaa)化合物およびそれらの使用 Withdrawn JP2009534458A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74563006P 2006-04-26 2006-04-26
GB0608269A GB0608269D0 (en) 2006-04-26 2006-04-26 Therapeutic compounds
PCT/GB2007/001537 WO2007125331A2 (en) 2006-04-26 2007-04-26 Amino-ethyl-amino-aryl (aeaa) compounds and their use

Publications (2)

Publication Number Publication Date
JP2009534458A JP2009534458A (ja) 2009-09-24
JP2009534458A5 true JP2009534458A5 (https=) 2010-06-17

Family

ID=38581449

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009507166A Withdrawn JP2009534458A (ja) 2006-04-26 2007-04-26 アミノ−エチル−アミノ−アリール(aeaa)化合物およびそれらの使用

Country Status (8)

Country Link
US (1) US20090247519A1 (https=)
EP (1) EP2024333A2 (https=)
JP (1) JP2009534458A (https=)
AU (1) AU2007245496A1 (https=)
CA (1) CA2649995A1 (https=)
IL (1) IL194899A0 (https=)
MX (1) MX2008013718A (https=)
WO (1) WO2007125331A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2707449A1 (en) * 2006-12-01 2009-06-12 President And Fellows Of Harvard College Compounds and methods for enzyme-mediated tumor imaging and therapy
CN101778825A (zh) * 2007-03-22 2010-07-14 沃泰克斯药物股份有限公司 适用作詹纳斯激酶抑制剂的n-杂环类化合物
JP2011522860A (ja) 2008-06-10 2011-08-04 ノバルティス アーゲー 上皮性ナトリウムチャネルブロッカーとしてのピラジン誘導体
AU2009256574A1 (en) * 2008-06-13 2009-12-17 Novartis Ag 2,4'-bipyridinyl compounds as protein kinase D inhibitors useful for the treatment of IA heart failure and cancer
WO2010142027A1 (en) * 2009-06-12 2010-12-16 Socpra - Sciences Et Genie S. E. C. Guanine riboswitch binding compounds and their use as antibiotics
WO2011036074A1 (en) * 2009-09-24 2011-03-31 Basf Se Aminoquinazoline compounds for combating invertebrate pests
EP2528606B1 (en) * 2010-01-28 2014-09-24 Alexander Levitzki Quinazoline-based t cell proliferation inhibitors
EP2550361B1 (en) * 2010-03-25 2017-02-08 The J. David Gladstone Institutes Compositions and methods for treating neurological disorders
CA3056970A1 (en) 2017-03-21 2018-09-27 Bayer Pharma Aktiengesellschaft 2-methyl-quinazolines
CA3097231A1 (en) 2018-04-18 2019-10-24 Bayer Pharma Aktiengesellschaft 2-methyl-aza-quinazolines
KR102831570B1 (ko) 2018-05-04 2025-07-10 레미디 플랜, 인크. 암 줄기 세포를 표적화하는 암 치료
JP2022544700A (ja) * 2019-08-22 2022-10-20 バイオヘイブン・セラピューティクス・リミテッド 筋萎縮性側索硬化症および関連障害の治療のためにtdp-43に結合する分子
CA3188260A1 (en) * 2020-08-07 2022-02-10 Dimitrios Iliopoulos Small molecules for the treatment of autoimmune diseases and cancer
EP4301348A1 (en) 2021-03-03 2024-01-10 Instytut Biologii doswiadczalnej imienia Marcelego Nenckiego Polskiej Akademii Nauk Inhibitor of protein kinase d for use in prevention or treatment of hyperlipidemia
EP4052700A1 (en) * 2021-03-03 2022-09-07 Instytut Biologii doswiadczalnej imienia Marcelego Nenckiego Polskiej Akademii Nauk Inhibitor of protein kinase d (pkd) for use in prevention or treatment of obesity and a pharmaceutical composition for such use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479504B1 (en) 1999-06-16 2002-11-12 The University Of Iowa Research Foundation Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases
JP4272338B2 (ja) 2000-09-22 2009-06-03 バイエル アクチェンゲゼルシャフト ピリジン誘導体
DE60236322D1 (de) 2001-12-07 2010-06-17 Vertex Pharma Verbindungen auf pyrimidin-basis als gsk-3-hemmer
AU2003255482A1 (en) 2002-10-02 2004-04-23 Merck Patent Gmbh Use of 4 amino-quinazolines as anti cancer agents
CL2004000409A1 (es) 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
EP1638955A2 (en) 2003-07-02 2006-03-29 Vertex Pharmaceuticals Incorporated Pyrimidines useful as modulators of voltage-gated ion channels
CR9465A (es) 2005-03-25 2008-06-19 Surface Logix Inc Compuestos mejorados farmacocineticamente

Similar Documents

Publication Publication Date Title
JP2009534458A5 (https=)
CN105906617B (zh) Hec1活性调节剂及其方法
JP6031122B2 (ja) 抗微生物療法のための三環式ホウ素化合物
JP2014501766A5 (https=)
EP4116291A1 (en) Synthesis of novel ep4 antagonist and use in cancers and inflammations
CN101952257A (zh) 苯并咪唑化合物
An et al. The discovery of a potent and selective third-generation EGFR kinase inhibitor as a therapy for EGFR L858R/T790M double mutant non-small cell lung cancer
JP2020506970A5 (https=)
KR20130121857A (ko) 다발성 골수종의 치료 효과를 갖는 피라졸 화합물
CN106749097B (zh) 一种6-氯-2-氨基苯并噻唑类衍生物及其制备方法和应用
US20160340321A1 (en) Substituted 1,2,3-Triazoles as Antitumor Agents
US11787790B2 (en) Benzimidazole derivative having fluorine-containing substituent, preparation and application thereof
JPWO2020219650A5 (https=)
RU2510394C1 (ru) Производное селеназола, имеющее лиганд, который активирует рецептор, активируемый пролифератором пероксисом ( ppar ), способ его получения и применение химических соединений
WO2019105234A1 (zh) 芳香族化合物及其药物组合物和用途
JP5701387B2 (ja) ベルバミンのジカルボキシミド誘導体、その調製方法及び使用
CN115867542A (zh) 新型苯并咪唑化合物
CN110305123B (zh) 一种含有金刚烷的化合物及其在治疗癌症中的用途
JP7679090B2 (ja) 置換ヒドロキシスチルベン化合物および誘導体、合成ならびにそれらの使用
JP2021534084A5 (https=)
CN104974171B (zh) 二氢青蒿素苯基醚衍生物及其应用
US10774046B2 (en) Inhibitors for the treatment of cancer and related methods
KR102578288B1 (ko) 피라졸로피리다진 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물
CN102675194B (zh) 含肟类的氨基衍生物、其药物组合物、其制备方法及用途
CN105481781A (zh) 化合物及其制备方法和应用